券商晨会精华 | 关注脑机接口及其拓展应用

Market Overview - The market opened strongly, with the ChiNext Index leading the gains, and the Shanghai Composite Index returning above 4000 points, recording twelve consecutive days of gains. The total trading volume in the Shanghai and Shenzhen markets reached 2.55 trillion, an increase of 501.1 billion compared to the previous trading day. The Shanghai Composite Index rose by 1.38%, the Shenzhen Component Index by 2.24%, and the ChiNext Index by 2.85% [1]. Industry Insights - CITIC Securities highlighted that the nuclear fusion sector is entering a period of intensive catalytic release, with significant technological advancements expected to drive a synchronized market trend between domestic and international markets early next year. The long-term growth trend of the industry has been established, with domestic capital expenditure progressing steadily and overseas developments likely to exceed expectations [2]. - Open Source Securities noted that gaming could serve as a significant application scenario for brain-computer interfaces (BCIs) and AI. The recent launch of China's first fully implanted, wireless BCI product by Shanghai Brain Tiger Technology marks a critical breakthrough in core BCI technology, enabling previously disabled individuals to engage in gaming through brain control. Elon Musk's Neuralink plans to mass-produce BCI chips by 2026, with a streamlined and automated implantation process expected to accelerate the maturity of various application scenarios, including gaming and medical rehabilitation [3]. - CITIC Construction Investment pointed out that the AI medical sector is expected to see continuous progress in policy, technology, products, and applications by 2025. The application of AI in healthcare is anticipated to expand from large hospitals to grassroots and individual levels, enhancing medical device functionality, interpreting test results, assisting clinical decision-making, and health management. The ongoing support from national policies and industry technologies is likely to accelerate the implementation of AI medical applications, presenting investment opportunities in the sector [4].